30 Day Trial

Amplitude Surgical Reports 1HFY16 Revenue

Share:

Amplitude Surgical posted FY1H16 (7/15-12/15) sales of €34.4MM (~US $37.7MM), +13.4% vs. the previous year. Growth reflects constant currency.

Amplitude South Africa has been established, and regulatory approval granted for its entire hip, knee and foot reconstruction range. 

Source: Amplitude Surgical

 

In 4Q15, Amplitude posted FY1Q16 revenue of €14MM (~US $15.1MM), +10.9% vs. the prior year, and reported regulatory approvals from the Australian Therapeutic Goods Administration for its Novastep foot product range and its Anatomic knee device.